A few years ago, the EULAR agreed on a definition for “difficult-to-treat” rheumatoid arthritis (RA). The reasons for multiple treatment failures are not yet fully understood. Research projects are trying to shed light on this. In this context, patient-related and disease-specific characteristics are analyzed at baseline and during the course of the disease. The identification of modifiable risk factors in the early stages of RA could possibly make preventive measures possible.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Epilepsy
The treatment of refractory status epilepticus – an overview
- Compression
Lymphoedema and chronic wounds
- Podiatry support to improve quality of life
Patient mobility with a foot wound
- Rare diseases
Cogan syndrome – a clinical challenge
- Polymyalgia rheumatica and giant cell arteritis
New consensus paper recommends “treat-to-target” strategy
- Threat from Aedes mosquitoes
Dengue, Zika and Chikungunya viruses on the rise
- Systemic lupus erythematosus
DORIS and LLDAS are also worthwhile for severe cases
- Malnutrition in old age